Current trend in escalating R&D expenditure and decreasing productivity levels have put increased pressure on managing the portfolio in order to maximize revenues. Achieving goal of maximized asset base, extending lifecycles, optimal resource allocation, and creating satisfying ROI thru affective prioritization of project portfolio, has become essential in order to maintain a competitive edge and to survive in this challenging period. Thus, efficient project portfolio management guides pharmaceutical companies through periods of slow growth and deliver shareholder confidence in potential future development.

You can join us on:

REQUEST THE FULL CONFERENCE BROCHURE HERE!

Key Topics

• Effectively Managing Project Portfolio in Changing Economic & Regulatory Environment
  
  
• Continued Focus on Resource Allocation & Execution of PPM
  
  
• Innovative Strategies & Models for R&D Portfolio Success
  
  
• Global Trends in R&D Outsourcing and Partnering
  
  
• New Drug Discovery & Risk Management

In the Chair

Dr. Markus Thunecke | Catenion, Germany
Senior Partner

Prestigious Speaker Panel

Dr. Victor Raczkowski | Solvay Pharmaceuticals
Senior Vice President, Head of US Regulatory Affairs & GRA Liaison Intelligence

Paul Biondi | Bristol Myers Squibb
Vice President - R&D Operations

Dr. Orest Hurko | Pfizer Inc.
Assistant Vice President Discovery Translation Reserach

James Kirwin | Pfizer Inc.
Assistant VP - Clinical Resources & Process Development & Clinical Development Operations

Christopher Beck | Shire Pharmaceuticals
VP, Program Resource & Decision Support

George Marmo | Bayer Healthcare
Director - Regional Program Management

Dr. Thomas Hampe | Amgen
Global Project Director -R&D Project Management

Phil Beccue | Baxter Healthcare
Director - Strategy & Portfolio Management

Dr. Jeffrey Handen | Merck & Co.
R&D Portfolio Management

Dr. Jane Relton | Biogen Idec
Associate Director - Program and Alliance Management

Florian Jehle | Catenion, Germany
Manager

Michael J. Menard | The GenSight Group
President & Co-founders

Expert Advisory Board

Pharm.D. Joseph Scheeren | Bayer Pharmaceuticals
Senior Vice President - Head of Global Regulatory Affairs

Dr. Rick Mayes | University of Richmond Associate Professor of Public Policy - Political Science Department
University of California /Berkeley/ - Faculty Research & Fellow - Petris Center on Healthcare Markets

Dr. Michele Mercuri | Daiichi Sankyo
Vice President - Acting Head of the Dept. of Cardiovascular Medicine, Global Development

Trupti Trivedi | GlaxoSmithKline Pharmaceuticals
Vice President - Strategy and Governance, Medicines Development

Michelle Zupancic | Roche
Vice President - New Products Planning >

Dr. Nahed Ahmed | Amgen
Vice President - Program Management & Strategic Operations

Dr. Suzanne K. Brown | Merck & Co.
Executive Director - R&D Portfolio Management Resource & Decision Management

Dr. Mak Jawadekar | Pfizer Inc.
Director - Portfolio Management & Analytics

REQUEST THE FULL CONFERENCE BROCHURE HERE!

If you are interested in speaking or sponsorship opportunities please contact:

Maros Petres

Project Director - Life Sciences
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
phone: 646-291-8903
fax: 212-726-3037

For more information about accomodation, travel or any other enquires please contact:


Veronika Bencova

Event Coordination
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
phone: 646-452-9504
fax: 212-726-3037

Gold Sponsors:

PAREXEL Consulting provides integrated product development consulting services, helping biopharmaceutical and medical device companies shorten time to market and maintain product viability for the long-term. Through our unique fusion of scientific, regulatory, and business expertise, we also help clients manage risk, and maximize product and portfolio value at every milestone and phase of development worldwide. Product development and portfolio management services with approval and market access in mind!

The GenSight Group is an international firm that assists large, complex enterprises with the mission-critical task of effectively allocating resources to the optimal mix of business initiatives. GenSight specializes in portfolio management, project management and resource optimization for companies in complex, rapidly-changing business environments. GenSight helps clients align project investments with strategy by integrating a consistent, strategic decision-making capability at all levels of the organization. They were recognized by The Forrester Group in December 2009 as one of the top 12 Portfolio Management providers in the world. A partial list of GenSight’s delighted clients includes Johnson & Johnson, Celgene, Cisco, FedEx, and British Telecom.

Silver Sponsor:

Catenion is a management consulting firm devoted to helping pharmaceutical and medical products companies create more innovative and effective strategies and organisations and significantly increase their returns on R&D.


Exhibitor:

Integrated Project Management Company, Inc. (IPM) Since 1988, IPM has been a leading provider of onsite project management services for the Life Sciences industry. IPM works with clients to solve critical business challenges in product development, alliance management, process improvement, technology transfer, commercialization and regulatory/quality compliance. IPM has been a pioneer in applying excellence in project management to deliver results. IPM has offices in Boston, Chicago, St. Louis, and San Francisco. Contact us at www.ipmcinc.com .


Media Partners:

Pharmaceutical International is a medical information and suppliers directory delivering the latest pharmaceutical news and information to users around the world. The portal forms an invaluable business resource for industry professionals, providing complete supplier profiles searchable by their products and services. The features offered by Pharmaceutical International also include detailed events and exhibition listings, videos and image galleries, supplier article publications and the latest contracts and tenders


Pharma Marketing News is an independent monthly electronic newsletter focused on issues of importance to pharmaceutical marketing executives. It is a service of the Pharma Marketing Network -- The First Forum for Pharmaceutical Marketing Experts -- which brings together pharmaceutical marketing professionals from manufacturers, communications companies, and marketing service providers for wide ranging discussions and education on a multitude of current topics. Pharma Marketing Network & Pharma Marketing News provide executive-level content coupled with permission-based e-marketing opportunities.

With a BPA-qualified circulation of 18,250† clinical trial professionals worldwide, Applied Clinical Trials is the authoritative, peer-reviewed resource and thought leader for the global community that designs, initiates, manages, conducts and monitors clinical trials. Industry professionals learn effective and efficient solutions to strategic and tactical challenges within the tightly regulated, highly competitive pharmaceutical environment.